New hope for kidney patients: finerenone aims to slow disease damage
NCT ID NCT07181135
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 27 times
Summary
This study tests whether the drug finerenone can lower protein in the urine (a sign of kidney damage) better than a placebo in 180 adults with chronic kidney disease who are not taking certain blood pressure medicines. Participants will take finerenone or a dummy pill for 6 months. The goal is to see if finerenone can help control the disease and reduce the risk of kidney failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clínica Universidad de Navarra
Madrid, Spain
-
Clínica Universidad de Navarra
Pamplona, Spain
-
Hospital Clinico Universitario de Valencia
Valencia, Spain
-
Hospital Universitari Germans Trias i Pujol
Barcelona, Spain
-
Hospital Universitario Dr Peset
Valencia, Spain
-
Hospital Universitario Puerta de Hierro
Madrid, Spain
-
Hospital Universitario de La Princesa
Madrid, Spain
-
Vall d'Hebron University Hospital
Barcelona, Spain
Conditions
Explore the condition pages connected to this study.